Colorectal Cancer

Find a Clinical Trial related to colorectal cancer, rectal cancer trials and colon cancer clinical trials
Disease Background
  Description of Colorectal Cancer
  Who is at Risk for Colorectal Cancer?
  National Cancer Institute Dictionary
 
Our Research
  Overview of Hutchinson Center Colorectal Cancer Research
 
Research Highlights
  Reducing colorectal-cancer risk
  Screening out colorectal cancer
 
Relevant Articles
  Hutchinson Center Publications Related to Colorectal Cancer
 
Colorectal Cancer Treatment at the SCCA
  Colorectal Cancer Program
 
Relevant Programs and Links
  Survivorship Program
End Colon Cancer Now campaign


Background of Colorectal Cancer

Description of Colorectal Cancer

The colon is a major organ in the final processing of nutrients. The colon is the first six feet of the large intestine, and the rectum is the last eight to ten inches. Cancers may affect the colon (colon cancer) or the rectum (rectal cancer).

Cancer in the colon or rectum starts with a growth that is not yet cancer. Center researchers are working to better understand what triggers the development of cancer. Testing helps to find and remove growths early; the chances of beating or avoiding colorectal cancer greatly increase with regular testing and early detection.

Surgery and radiation therapies are the most common treatments for colorectal cancer. Sometimes chemotherapy may be used. If cancer is found in small polyps, benign growths on the inner wall of the colon or rectum, it can be treated without major surgery.

[ Back to Top ]
Who is at Risk for Colorectal Cancer?

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the United States and the second most common cause of cancer death. In 2007, nearly 154,000 new cases will be diagnosed nationwide, and more than 52,000 will die from the disease. It is more likely to occur as people get older and is most common in people over the age of 50. Colorectal cancer is more common in some families and certain conditions like ulcerative colitis, a history of polyps or in women with a history of ovarian or uterine cancer. Many factors have been found to be associated with CRC, such as low levels of physical activity, smoking, alcohol consumption, high body weight, prior history of polyps of the colon or rectum, low intake of fruits and vegetables and high meat consumption. Other factors have been associated with reduced risk such as a diet rich in plant foods, use of non-steroidal anti-inflammatory drugs (like aspirin) and postmenopausal hormones.

[ Back to Top ]

Hutchinson Center Colorectal Cancer Research

Overview of Hutchinson Center Colorectal Cancer Research

Hutchinson Center colorectal cancer research is primarily focused on discovering ways to reduce a person's risk of colorectal cancer and developing new ways to detect colorectal cancer at its earliest, most treatable stages. Colorectal-cancer treatment, including clinical trials of new therapies, is offered at the Seattle Cancer Care Alliance.

Reducing the risk of colorectal cancer

The best way to eliminate colorectal cancer is to prevent it from ever occurring. The Hutchinson Center houses the world's largest and longest-standing cancer-prevention research program, dedicated to discovering the factors that influence a person's likelihood of developing cancer — and using that knowledge to develop and test ways that people can reduce their cancer risk and lead healthier lives. Colorectal-cancer prevention projects include:

  • The Seattle Familial Colorectal Cancer Registry (S-CFR) is one of six sites in the Cooperative Family Registry for Colorectal Cancer Studies (Colon CFR). This international registry collects information and tissue specimens from colorectal-cancer patients, their family members and other individuals. This data enables researchers to understand how a person's unique genetic makeup, interacting with their medical history and life-style, may contribute to the risk of colorectal cancer.


  • The Aspirin and the Biology of the Colon (ABC) study is investigating why regular aspirin use reduces colon cancer risk by 50 percent in some individuals but not others. The ABC study aims to understand how genes that control the body's digestion of aspirin may affect its effectiveness in lowering colorectal-cancer risk.


  • The APPEAL study (A Program Promoting Exercise and Active Lifestyles) is the first to look specifically at how moderate to vigorous intensity exercise may lower risk of colon polyps and colon cancer development.
  • Read more about cancer-prevention or early detection studies that are recruiting participants.

    [ Back to Top ]

    Screening out colorectal cancer

    If all colorectal cancer cases were now detected at their earliest stages, five-year survival rates for the disease would jump from 64 to 90 percent. Hutchinson Center scientists are developing new ways to detect colorectal cancer at its earliest, most curable stages.

  • Although colonoscopy is a highly effective screening test for colorectal cancer, the anticipated discomfort of the procedure causes many individuals to avoid having one. Compliance with screening guidelines — which recommend a colonoscopy ever 10 years for individuals over age 50 — are only about 16 to 20 percent. Hutchinson Center scientists are working to develop a safe, accurate and easy-to-administer test that picks up colorectal-cancer warning signals in the DNA found in a blood or stool sample. Such a test would likely encourage more people to undergo screening. It also would limit the use of colonoscopy to those found to be at risk for cancer by the DNA test, who would then undergo the procedure to have polyps removed.


  • About 5 percent of all colorectal cancer cases are due to one of several inherited syndromes that confer an exceptionally high risk for developing the disease at an early age. Those with these and other hereditary cancer syndromes may benefit from a visit to the Gastrointestinal (GI) Cancer Prevention Program, a multidisciplinary clinic at the Seattle Cancer Care Alliance and the University of Washington for people known to be at high risk for colorectal, gastric and pancreatic cancer. Examples of someone at high risk include those with a family member who has been diagnosed with one of these cancers at an early age. The clinic provides risk assessment for such individuals and their family members, including genetic testing and counseling for known hereditary cancer syndromes. Based on results of the risk assessment, individuals will receive individualized cancer surveillance recommendations and will be offered opportunities to participate in clinical trials aimed at cancer prevention and detection.
  • [ Back to Top ]

    Articles Related to Colorectal Cancer and Colorectal Cancer Information

    Hutchinson Center Publications

  • Weighing costs and outcomes to strengthen disease prevention and treatment options

  • Running may reduce cancer risk

  • Economic realities, gender beliefs hinder access to screening

  • Breaking cancer's family ties

  • NSAIDs are not enough

  • A comfortable colorectal test — Clinical researcher William Grady aims to improve colorectal-cancer survival by developing a screening test people are more likely to undergo

  • Colorectal screening saves lives, money — New PHS study shows simple colorectal-cancer test catches cancers earlier, significantly reduces health-care costs

  • Fewer colon tests needed? — Public Health Sciences study suggests colorectal screening every 10 years may significantly lower colon-cancer incidence

  • Search for More Colorectal Cancer Publications and Colorectal Cancer Information »

    [ Back to Top ]


    Fred Hutchinson Cancer Research Center
    1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
    ©2008 Fred Hutchinson Cancer Research Center, a nonprofit organization.
    Terms of Use & Privacy Policy.